Market News / Story
bioAffinity Technologies, Inc. Announces Closing of $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced …
BusinessWire ·
BusinessWire reports: bioAffinity Technologies, Inc. (, BIAFW) , a biotechnology company developing noninvasive healthcare solutions for the early detection and monitoring of lung disease, today announced that it has closed its previously announced registered direct offering of shares of common stock (or pre-funded warrants in lieu thereof) with an institutional investor at a purchase price of $6.122 (or $6.115 per pre-funded warrant), in a registered direct offering priced at-the-market…
Related stories
Trump bought up to $25 million in Meta and millions in SpaceX debt in AugustRead story summary
President Donald Trump disclosed more than 500 securities transactions in August, including a purchase of up to $25 million in Meta stock and an investment of as much as $5 million in SpaceX debt two days before he signed a sweeping policy aimed at expanding U.S. commercial space transportation, according to a newly released financial disclosure. The 517 ...
VIEW SOURCE